About
Monoclonal Antibody Therapy for Blood and Bone Cancer
Pink Biopharma is a drug-discovery company that is developing a therapeutic monoclonal antibody as a natural-killer immune checkpoint inhibitor for a variety of cancers, specifically acute myeloid leukemia. The company is a portfolio company of the FutuRx biotech incubator.
Identity
| Name | Pink Biopharma |
|---|---|
| Slug | pink-biopharma |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMOo3csIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jul 2021 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | |
| HQ address | Ilan Ramon 2, Ness Ziona, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
cellsdrug-discoveryantibodiespharmaceuticalsoncologycancerimmunotherapyimmunologybiotechnologyhospitals
Funding
| Total raised | $3.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}